drugset / Trial / NCT00906035
The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)
RandomizedParallel-groupTriple-blindTreatment
Summary
This research study will evaluate the effects of aspirin and dipyridamole alone and in combination on the blood flow in the vessels of the legs. We will examine how these medications are able to inhibit the clotting of platelets in the vessels of patients with PAD, and thereby affect the blood flow in the legs. Platelets are cells in the blood that have the ability to adhere to each other to form clots.
Timeline
- Start
- 2002-09
- Primary completion
- 2010-03
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 25 mg | — |
| Comparator | Dipyridamole | Other / unclassified | 200 mg | — |